title: New Models of Therapy: When Acute Leukemia Becomes Chronic.
authors.affiliation: Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota. Electronic address: custun@umn.edu.
authors.forename: Celalettin
authors.initials: C
authors.lastname: Ustun
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
authors.forename: Richard
authors.initials: R
authors.lastname: Stone
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
authors.forename: Daniel
authors.initials: D
authors.lastname: Weisdorf
mesh_terms: D018450:Disease Progression; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000201:enzymology; D060046:Maintenance Chemotherapy / Q000379:methods; D034721:Mastocytosis, Systemic / Q000188:drug therapy / Q000201:enzymology; D058990:Molecular Targeted Therapy / Q000379:methods*; D020125:Mutation, Missense; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors*; D017354:Point Mutation; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000201:enzymology; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D019009:Proto-Oncogene Proteins c-kit / Q000037:antagonists & inhibitors / Q000235:genetics; D020080:Tandem Repeat Sequences; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors / Q000235:genetics
chemical_list: D009363:Neoplasm Proteins; D047428:Protein Kinase Inhibitors; C497970:FLT3 protein, human; D011505:Protein-Tyrosine Kinases; D019009:Proto-Oncogene Proteins c-kit; D051941:fms-Like Tyrosine Kinase 3; D016044:Fusion Proteins, bcr-abl